Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $21.39 $26.48 Wednesday, 8th May 2024 ARWR stock ended at $25.22. This is 0.88% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.99% from a day low at $24.30 to a day high of $25.27.
90 days $21.39 $36.72
52 weeks $20.67 $41.28

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
May 26, 2016 $5.84 $5.84 $5.84 $5.84 377 724
May 25, 2016 $5.88 $5.88 $5.88 $5.88 393 319
May 24, 2016 $5.75 $5.75 $5.75 $5.75 368 727
May 23, 2016 $5.64 $5.64 $5.64 $5.64 476 241
May 20, 2016 $5.42 $5.42 $5.42 $5.42 684 093
May 19, 2016 $5.01 $5.01 $5.01 $5.01 736 815
May 18, 2016 $4.99 $4.99 $4.99 $4.99 530 090
May 17, 2016 $4.95 $4.95 $4.95 $4.95 748 153
May 16, 2016 $5.09 $5.09 $5.09 $5.09 822 364
May 13, 2016 $5.23 $5.23 $5.23 $5.23 732 898
May 12, 2016 $5.33 $5.33 $5.33 $5.33 625 658
May 11, 2016 $5.58 $5.58 $5.58 $5.58 752 892
May 10, 2016 $5.72 $5.72 $5.72 $5.72 544 440
May 09, 2016 $5.76 $5.76 $5.76 $5.76 511 220
May 06, 2016 $5.59 $5.59 $5.59 $5.59 727 842
May 05, 2016 $5.67 $5.67 $5.67 $5.67 416 511
May 04, 2016 $5.74 $5.74 $5.74 $5.74 477 867
May 03, 2016 $5.81 $5.81 $5.81 $5.81 309 908
May 02, 2016 $6.02 $6.02 $6.02 $6.02 479 908
Apr 29, 2016 $5.79 $5.79 $5.79 $5.79 473 671
Apr 28, 2016 $5.92 $5.92 $5.92 $5.92 480 134
Apr 27, 2016 $5.94 $5.94 $5.94 $5.94 710 999
Apr 26, 2016 $6.01 $6.01 $6.01 $6.01 839 238
Apr 25, 2016 $6.24 $6.24 $6.24 $6.24 459 610
Apr 22, 2016 $6.26 $6.26 $6.26 $6.26 395 259
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT